Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles
Upperton advances sterile manufacturing facility following MHRA submission.
News
Upperton Pharma Solutions Recognised as One of The Sunday Times Best Places to Work 2026
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2026
Upperton Named Dual Winner at Medilink Midlands Awards, Underscoring Continued Growth and Commitment to Innovation
Upperton announces its recognition as winner of the Small Molecule Dosage Form category at the inaugural European CDMO Leadership Awards.
Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
Business Development Spotlight with Christopher Bjerkan Wade
Discover more about our team. In this Spotlight, meet our Senior Business Development Director, Christopher Bjerkan Wade.
Upperton Wins at European Celebration of CDMO Excellence: Winner of Small Molecule Dosage Form Category
Upperton announces its recognition as winner of the Small Molecule Dosage Form category at the inaugural European CDMO Leadership Awards.
Upperton Expands High Precision Filling Capability at Nottingham Facility
Upperton has increased its filling capability with the installation of the Fill2Weight gravimetric powder filling machine from 3P innovation
Upperton Pharma Solutions Raises over £4,000 for Children’s Charity, Rainbows Hospice
Upperton Pharma have raised over £4,000 for Rainbows, the children’s hospice serving families in Loughborough and across the East Midlands.
Upperton wins Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025
Upperton wins the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025.
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery in Partnership with the University of Oxford’s Pandemic Sciences Institute
Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.